Navigation Links
Sanofi US and POZEN Sign Exclusive License Agreement for the Commercialization of PA8140/PA32540 Tablets in the U.S.
Date:9/4/2013

BRIDGEWATER, N.J. and CHAPEL HILL, N.J., Sept. 4, 2013 /PRNewswire/ -- Sanofi US (NYSE: SNY) and POZEN Inc. (NASDAQ: POZN) announced the signing of an exclusive license agreement for the commercialization of POZEN's proprietary, investigational, coordinated-delivery tablets combining immediate-release omeprazole, a proton pump inhibitor (PPI), and enteric-coated (EC) aspirin in a single tablet ("PA"), PA8140 and PA32540. Under the terms of the agreement, Sanofi will have exclusive rights to commercialize all PA combinations that contain 325 mg or less of enteric-coated aspirin in the United States. POZEN will receive an upfront payment of $15MM and will be eligible for pre-commercial milestone payments of up to $20MM and other future milestone payments and royalties on product sales.

(Logo: http://photos.prnewswire.com/prnh/20110616/NY20158LOGO)

"Sanofi has a strong heritage and expertise in the cardiovascular space, with Lovenox, Plavix, and most recently Multaq, and the PA products are an important addition to our already strong CV portfolio," said Anne Whitaker, President, North America Pharmaceuticals at Sanofi US. "The PA products have the potential to be an effective solution for the millions of patients at risk for gastric ulcers from chronic aspirin use in the prevention of secondary cardiovascular disease. We look forward to bringing this therapy to patients and healthcare providers."

Sanofi US will have responsibility for all sales, marketing, ongoing manufacturing and future development for the licensed PA products in the U.S.  POZEN will retain responsibility for obtaining approval o
'/>"/>

SOURCE Sanofi US
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Sanofi Pasteurs Fluzone High-Dose Vaccine Significantly More Effective Than Standard Dose Fluzone Vaccine in Preventing Influenza in Adults 65 Years of Age and Older
2. Sanofi Pasteur Announces Shipment of First Lots of 2013-2014 Seasonal Influenza Vaccine in U.S.
3. Sanofi US and Joslin Diabetes Center Announce Results from Multicultural Outreach Pilot at American Diabetes Association Scientific Sessions
4. Sanofi Announces Positive Phase 3 Results for Investigational New Insulin U300
5. Sanofi Announces Positive Phase 3 Data for Once-Daily Lixisenatide for Type 2 Diabetes
6. Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine
7. Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
8. The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals
9. Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)
10. Tolero Pharmaceuticals announces Worldwide Agreement with Sanofi for the In-license of Alvocidib (Flavopiridol)
11. NextBio Announces Translational Medicine Partnership with Sanofi
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014 Lpath, ... leader in bioactive lipid-targeted therapeutics, reported interim results ... ASONEP™ is being investigated as a treatment for ... have failed at least one therapy involving a ... more than one mTOR inhibitor (e.g., Afinitor®/everolimus), with ...
(Date:7/24/2014)... 24, 2014  Market Diagnostics International LLC ("MDxI") ... LabFile , a data resource that sets a ... universe and identifying target In Vitro Diagnostics (IVD) ... that provides IVD manufacturers with accurate and comprehensive ... clear and consistent definitions of laboratory categories and ...
(Date:7/24/2014)... SAN DIEGO , July 24, 2014 /PRNewswire/ ... company, announced today a co-promotion agreement with Illumina ... whole genome sequence data for precision medicine and ... offer pharmaceutical companies, through Illumina,s sales force, a ... NextBio platform for data analytics and storage, and ...
Breaking Medicine Technology:Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP 2Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP 3Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP 4MDxI Launches Data Resource Setting New Standard for Defining and Targeting US Clinical Laboratory Universe 2Cypher Genomics and Illumina Enter Agreement to Facilitate Genomic Biomarker Discovery 2Cypher Genomics and Illumina Enter Agreement to Facilitate Genomic Biomarker Discovery 3
... The SCOOTER Store , the nation,s leading ... Berger as Chief Marketing Officer.  In the CMO role, ... improvement of the company,s marketing plan and branding.  Berger ... and is responsible for planning, directing and coordinating the ...
... PARSIPPANY, N.J., Sept. 22, 2011 Watson Pharmaceuticals, Inc. ... Pharmaceuticals, Inc. and Sandoz Inc. have filed suit against ... in the United States District Court for the District ... Injection product, which Watson has the exclusive right to ...
Cached Medicine Technology:The SCOOTER Store Appoints New Chief Marketing Officer 2Watson Confirms Amphastar Patent Lawsuit 2Watson Confirms Amphastar Patent Lawsuit 3
(Date:7/24/2014)... new study estimates that more than 10 million uninsured ... to the Affordable Care Act. The biggest gains ... federal insurance program for the poor. Under health care ... about expanding eligibility. "This study reaffirms that the ... toward achieving that goal," Health and Human Services Secretary ...
(Date:7/24/2014)... PA (PRWEB) July 24, 2014 Hayes, ... health outcomes through the use of evidence, is pleased ... Services, will be a guest speaker at the ... 2014. Ms. Donatelli, an expert in value analysis who ... of Hospital Value Analysis Professionals (AHVAP), will facilitate and ...
(Date:7/24/2014)... July 24, 2014 Comparemedicalinsurance.info has ... life insurance for clients who have health problems. ... insurance difficult for many clients. No medical exam life ... can qualify for coverage a lot easier. , ... different types. Some offer temporary protection, while others will ...
(Date:7/24/2014)... 2014 6 Minutes to Skinny focuses ... into high gear with only a few minutes each ... diet or lifestyle. This has caught the attention of ... 6 Minutes to Skinny review shows that ... to understand exactly how your body responds to food ...
(Date:7/24/2014)... July 24, 2014 ReNewLifeCleansing.com was inspired ... Watson’s own personal health “makeover.” While waging her battle ... would be the foundation for her recovery. She became ... how specific blends of herbs, minerals, and other ingredients ... rid the body of unwanted waste and toxins for ...
Breaking Medicine News(10 mins):Health News:More Than 10 Million People Gained Coverage Under Obamacare, Study Finds 2Health News:Hayes, Inc. Senior Vice President to Speak at AHRMM14 Conference 2Health News:Hayes, Inc. Senior Vice President to Speak at AHRMM14 Conference 3Health News:Life Insurance Without Examinations for Clients Who Have Pre-Existing Medical Conditions 2Health News:6 Minutes to Skinny: Review Examining Craig Ballantyne’s Weight Loss Program Released 2Health News:6 Minutes to Skinny: Review Examining Craig Ballantyne’s Weight Loss Program Released 3Health News:ReNew Life Launches New Educational Cleansing & Detox Website—ReNewLifeCleansing.com 2
... experts recommend potential ban on use by people under 18, ... A potential ban on the use of tanning beds by ... health advisers who said more measures are needed to protect ... the devices. , The panel of advisers to the Food ...
... is improving in patients with metastatic breast cancer, especially ... HER2 (human epidermal growth factor receptor-2) positive, a surgical ... seventh European Breast Cancer Conference (EBCC7). Dr ... Kalmar, Sweden, will say that the median survival times ...
... Traveling ... any situation , ... 26, 2010 -- Recently, Americans have become apprehensive about traveling to Mexico whether for business ... know that it is completely safe to travel to the popular tourist and business destinations, ...
... ... sponsored by HealthCentral, May 18, 2010 at the Penn’s Landing Hyatt in Philadelphia. ... Florham Park, N.J. ... company for over-the-counter (OTC) marketing, today announced the finalists for the 2nd annual OTC ...
... ... former Bush speechwriter David Frum with his resume. Frum was fired by the American ... ... -- Paul Freiberger, the President of Shimmering Resumes, offers to help former Bush speechwriter ...
... ... determine which restaurant offers the healthiest fast food options , ... San Francisco, CA (PRWEB) March 26, 2010 -- March Madness ... Basketball Tournament, things are really heating up. In honor of this great American competition, Healthline.com ...
Cached Medicine News:Health News:FDA Advisers Urge Stricter Regulation of Tanning Beds 2Health News:FDA Advisers Urge Stricter Regulation of Tanning Beds 3Health News:Survival in metastatic breast cancer patients is improving: targeted therapies have contributed 2Health News:AssistCare Mexico Provides 24/7 Peace of Mind and Safety to Vacationers and Business Executives Traveling to Mexico 2Health News:OTC Perspectives Announces 2010 Ad Awards Finalists Presented by HealthCentral 2Health News:President of Shimmering Resumes Offers Professional Resume To Bush Speechwriter, David Frum 2Health News:Healthiest Fast Foods Revealed: Just in Time for the NCAA Tournament Sweet 16, Healthline.com Debuts Munchie Madness 2
This table provides the user with a moderatelypriced, yet fully versatile, electric table which will accept most HAAG-STREIT instruments as well as many of those from other ophthalmic manufacturers....
An antegrade femoral nail....
... Quad 4™ Intramedullary Nailing System was to ... used for the widest possible variety of ... were to minimize the number of implants ... system that could address antegrade or retrograde ...
... Xerox Copier Assistant software enables users who ... or have limited dexterity, to access and ... This software increases user productivity by leveraging ... interface, embedded text-to-speech software, and keyboard navigation ...
Medicine Products: